FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/03/041485 [Registered on: 30/03/2022] Trial Registered Prospectively
Last Modified On: 28/03/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Role of homoeopathic medicine in the management of pain in the abdomen 
Scientific Title of Study   Efficacy of homoeopathic medicine in the management of irritable bowel syndrome by using synthesis-repertorium homeopathicum syntheticum 9.1 repertory and to assess the quality of life 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  KARTHIK R S 
Designation  Post Graduate Scholar 
Affiliation  Vinayaka Missions Homoeopathic Medical College and Hospital 
Address  Department of Repertory OPD Room No 2C Vinayaka Missions Homoeopathic Medical College and Hospital NH 47 Sankari Main Road Seeragapadi PO Salem TAMIL NADU 636308 India

Salem
TAMIL NADU
636308
India 
Phone  8943899535  
Fax    
Email  karthikrs1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr J Senthil Kumar 
Designation  Professor and Head of Department 
Affiliation  Vinayaka Missions Homoeopathic Medical College and Hospital 
Address  Department of Repertory OPD Room No 2C Vinayaka Missions Homoeopathic Medical College and Hospital NH 47 Sankari Main Road Seeragapadi PO Salem TAMIL NADU 636308 India

Salem
TAMIL NADU
636308
India 
Phone  9842780556  
Fax    
Email  drjsenthil@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr J Senthil Kumar 
Designation  Professor and Head of Department 
Affiliation  Vinayaka Missions Homoeopathic Medical College and Hospital 
Address  Department of Repertory OPD Room No 2C Vinayaka Missions Homoeopathic Medical College and Hospital NH 47 Sankari Main Road Seeragapadi PO Salem TAMIL NADU 636308 India

Salem
TAMIL NADU
636308
India 
Phone  9842780556  
Fax    
Email  drjsenthil@gmail.com  
 
Source of Monetary or Material Support  
Vinayaka Missions Homoeopathic Medical College and Hospital NH 47 Sankari Main Road Seeragapadi PO Salem TAMIL NADU 636308 India 
 
Primary Sponsor  
Name  Vinayaka Missions Homoeopathic Medical College and Hospital  
Address  NH 47 Sankari Main Road Seeragapadi PO Salem TAMIL NADU 636308 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr J Senthil Kumar  Vinayaka Missions Homoeopathic Medical College and Hospital   Room No 2C-2 - PG Dept of Repertory OPD Unit Ground Floor Hospital Block Vinayaka Missions Homoeopathic Medical College and Hospital NH 47 Sankari Main Road Seeragapadi PO Salem TAMIL NADU 636308 India
Salem
TAMIL NADU 
9842780556

drjsenthil@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Vinayaka Missions Kirupananda Variyar Medical College And Hospital Salem  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K581||Irritable bowel syndrome with constipation, (2) ICD-10 Condition: K580||Irritable bowel syndrome with diarrhea, (3) ICD-10 Condition: K589||Irritable bowel syndrome without diarrhea, (4) ICD-10 Condition: K582||Mixed irritable bowel syndrome, (5) ICD-10 Condition: K588||Other irritable bowel syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic Medicines  Homoeopathic medicines are selected based on individualization. The dose is selected based on the susceptibility of the patient. Medicine is administered via oral route. Follow up is taken in every 15 days. Maximum treatment period per patient under study is 6 months 
Comparator Agent  Not Applicable  Not Applicable  
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All cases that fit into the ROME III diagnostic criteria, The patients of all age groups and both sexes, Patients who are pre diagnosed with IBS, Patients irrespective of ethnic groups socio economic status and occupation will be considered
 
 
ExclusionCriteria 
Details  Cases which does not fit Rome III criteria
Cases which have other systemic illness.
Cases with symptoms for less than 3 months
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Based on the Rome III criteria, clinical symptoms of irritable bowel syndrome are assessed  At baseline and after 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
it is expected that the proposed study will be useful in reducing the symptoms of irritable bowel syndrome and to improve the quality of life of the patients  At baseline And after 6 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   11/04/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Irritable Bowel Syndrome is one of the main psychosomatic disorders characterized by recurrent abdominal pain in abdomen, abdominal swelling, diarrhoea, constipation, eructation and flatulence and mucorrhea. In developed countries, its mainly seen in 10 – 15% adults. In India, IBS is seen in almost 4.2 % of the population. In Males the estimate is 4.3% and in females it is 4.0%.Younger people have higher prevalence of irritable bowel syndrome in the population. IBS is psychosomatic in origin and a result of modern life style and presents with lot of clinical symptoms. Experience says that Homoeopathy stands out for its Holistic approach towards diseases. Repertory stands greater height as best approach for any type of cases. Synthesis 9.1 is a very such tool which fulfils the requirement of ailments from, mental generals, physical generals and clinical symptoms., which I am using to find out the similimum. This study is the small attempt to highlight the efficacy of homeopathic similimum achieved by using Synthesis 9.1 repertory in treatment of Irritable Bowel Syndrome.

 
Close